Psyence Group Inc. PSYG.CN Stock
Psyence Group Inc. Price Chart
Psyence Group Inc. PSYG.CN Financial and Trading Overview
| Psyence Group Inc. stock price | 0.02 CAD |
| Previous Close | 0.12 CAD |
| Open | 0 CAD |
| Bid | 0.12 CAD x N/A |
| Ask | 0.13 CAD x N/A |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 0.18 CAD |
| Volume | 0 CAD |
| Avg. Volume | 14.61K CAD |
| Market Cap | 11.85M CAD |
| Beta (5Y Monthly) | -1.072978 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.05 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.55 CAD |
PSYG.CN Valuation Measures
| Enterprise Value | 10.84M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2139.501 |
| Price/Book (mrq) | 5.952381 |
| Enterprise Value/Revenue | 1956.662 |
| Enterprise Value/EBITDA | -2.612 |
Trading Information
Psyence Group Inc. Stock Price History
| Beta (5Y Monthly) | -1.072978 |
| 52-Week Change | 31.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.18 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.12 CAD |
| 200-Day Moving Average | 0.12 CAD |
PSYG.CN Share Statistics
| Avg. Volume (3 month) | 14.61K CAD |
| Avg. Daily Volume (10-Days) | 10.14K CAD |
| Shares Outstanding | 94.84M |
| Float | 91.21M |
| Short Ratio | 0.42 |
| % Held by Insiders | 4.30% |
| % Held by Institutions | 0% |
| Shares Short | 1.25K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -76337.72% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -65.18% |
| Return on Equity (ttm) | -153.78% |
Income Statement
| Revenue (ttm) | 5.54K CAD |
| Revenue Per Share (ttm) | 0 CAD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -4150578 CAD |
| Net Income Avi to Common (ttm) | -4383591 CAD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.87M CAD |
| Total Cash Per Share (mrq) | 0.02 CAD |
| Total Debt (mrq) | 1.27M CAD |
| Total Debt/Equity (mrq) | 62.83 CAD |
| Current Ratio (mrq) | 1.197 |
| Book Value Per Share (mrq) | 0.021 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3250539 CAD |
| Levered Free Cash Flow (ttm) | -4128746 CAD |
Profile of Psyence Group Inc.
| Country | Canada |
| State | ON |
| City | Toronto |
| Address | 200 Bay Street |
| ZIP | M5J 2J1 |
| Phone | N/A |
| Website | https://www.psyence.com |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.
Q&A For Psyence Group Inc. Stock
What is a current PSYG.CN stock price?
Psyence Group Inc. PSYG.CN stock price today per share is 0.02 CAD.
How to purchase Psyence Group Inc. stock?
You can buy PSYG.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Psyence Group Inc.?
The stock symbol or ticker of Psyence Group Inc. is PSYG.CN.
Which industry does the Psyence Group Inc. company belong to?
The Psyence Group Inc. industry is Drug Manufacturers-General.
How many shares does Psyence Group Inc. have in circulation?
The max supply of Psyence Group Inc. shares is 137.44M.
What is Psyence Group Inc. Price to Earnings Ratio (PE Ratio)?
Psyence Group Inc. PE Ratio is now.
What was Psyence Group Inc. earnings per share over the trailing 12 months (TTM)?
Psyence Group Inc. EPS is -0.05 CAD over the trailing 12 months.
Which sector does the Psyence Group Inc. company belong to?
The Psyence Group Inc. sector is Healthcare.